New drug JTM201 takes on Post-Stroke muscle stiffness in early trial
NCT ID NCT07292025
First seen Jan 06, 2026 · Last updated May 24, 2026 · Updated 21 times
Summary
This early-phase study tested a new medicine called JTM201 in 30 adults who had a stroke at least 6 months ago and still have stiff arm muscles. The goal was to see if JTM201 is safe and works better than Botox at reducing muscle tightness. Researchers measured changes in muscle stiffness and daily function over 12 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UPPER LIMB SPASTICITY POST-STROKE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Seoul Boramae Hospital
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.